The Pharmacy Times® Alzheimer Disease Resource Center is a comprehensive resource for clinical news and expert insights on treatments for Alzheimer disease.
April 4th 2025
BIIB080 is designed to target microtubule-associated protein tau mRNA, aimed to reduce the production of tau protein.
The Value of Pharmacists in Treating Alzheimer Disease
November 10th 2021A pharmacist can offer up to date knowledge on the clinical evidence behind new drugs, serving as a source of guidance for patients amongst the controversy with aducanumab and other new medications for Alzheimer disease.
Read More
Ongoing Developments and Barriers for Treatment of Alzheimer Disease
August 23rd 2021It is the responsibility of the pharmacist to remain informed of all existing and new drugs for the treatment of Alzheimer disease, especially because novel and investigational drugs may target the pathophysiology of the disease.
Read More